There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV strains, HPV-16 and HPV-18. GSK says it plans to seek FDA approval for Cervarix by the end of the year.

Cervarix, manufactured by GlaxoSmithKline, was approved Friday for prevention of cervical cancer and pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is ...

Ninety-nine percent of cervical cancers are caused by HPV. What is the Cervarix HPV vaccine? The Cervarix HPV vaccine protects against the two strains of HPV (16 and 18) that cause cervical cancer ...

The HPV vaccines Gardasil and Cervarix can effectively prevent infections from the most dangerous HPV strains associated with cancer development. However, timing proves critical when it comes to ...

Cervarix: population analyzed in this table were seronegative to HPV-16 and -18, and PCR DNA negative to 14 high-risk HPV types at study entry. Gardasil: population analyzed in this table were ...

Vaccine efficacy of 100% was observed against HPV-16/18-related cervical intraepithelial ... integrated safety analyses show that Cervarix has a favorable safety profile in diverse populations ...

HPV vaccines are safe and protect against many types of cancer including cervical, throat, and anal. Common HPV vaccine side effects should subside in 2 days and include dizziness, nausea ...

It was also caused by the human papillomavirus, or HPV. The treatment was brutal ... the Gardasil and Cervarix vaccines. Administered before a child risks exposure through sex, they not only ...